Media Coverage · March 8, 2017

Acticor Biotech, a key R&D deal after a successful funding round for the treatment in the acute phase of ischemic stroke

gazette-laboratoire-logo2

March 2017. La Gazette du Laboratoire publishes an article on Acticor Biotech: “Acticor Biotech, a key R&D deal after a successful funding round for the treatment in the acute phase of ischemic stroke.

Download full text article (PDF, French)

Read next in 'Media Coverage'